Kofarest-LS Syrup Delicious Mixed Fruit is a combination pharmaceutical formulation containing Ambroxol (30mg/5ml), Levosalbutamol (1mg/5ml), and Guaifenesin (50mg/5ml), designed to provide comprehensive relief from respiratory tract disorders characterized by cough, mucus hypersecretion, and bronchospasm. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of thick mucus from the airways, thereby improving expectoration and easing breathing. Levosalbutamol, a selective beta-2 adrenergic receptor agonist, functions as a bronchodilator by relaxing bronchial smooth muscles, which alleviates bronchospasm and reduces airway resistance. Guaifenesin serves as an expectorant, promoting the thinning and loosening of mucus in the respiratory tract, enhancing productive cough and mucus clearance. This synergistic combination is particularly beneficial in conditions such as acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory ailments involving mucus retention and airway constriction. The syrup’s palatable mixed fruit flavor improves patient compliance, especially in pediatric and geriatric populations. Kofarest-LS Syrup should be used under medical supervision, with dosage adjusted according to age, severity of symptoms, and clinical response, while monitoring for potential side effects such as tachycardia, tremors, or gastrointestinal discomfort.